Article Details

Henlius Receives IND Approval from NMPA for a Phase 1b/2 Clinical Trial of Its Novel PD ...

Retrieved on: 2024-12-06 21:56:08

Tags for this article:

Click the tags to see associated articles and topics

Henlius Receives IND Approval from NMPA for a Phase 1b/2 Clinical Trial of Its Novel PD .... View article details on hiswai:

Excerpt

Combining the selectivity of targeted monoclonal antibodies with the highly potent cytotoxic agent, HLX43 could exert anti-tumour effects through ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo